文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

基层医疗专业人员治疗阿片类药物使用障碍与2型糖尿病的意愿比较

Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care.
PubMed 文献 · JAMA Netw Open · 2025-09-02
一句话结论俄亥俄州基层医疗人员更愿意在基层治疗2型糖尿病而非阿片类药物使用障碍,但患者种族不影响治疗决策。

这项横断面研究采用2×2析因设计,随机将俄亥俄州375名基层医疗医生、执业护士和医生助理分配至阿片类药物使用障碍(OUD)或2型糖尿病、黑人或有白人种族的虚构患者档案。结果显示,参与者显著更愿意在基层治疗2型糖尿病(均值4.4 vs OUD组3.6),也更可能将OUD患者转诊至专科(4.4 vs 3.3)。患者种族未导致显著治疗差异。参与者对开具OUD药物呈中等意愿,对纳曲酮的意愿(3.7)略高于丁丙诺啡(3.4),最受认可的治疗是转诊至戒断为基础的住院治疗机构(3.9)。作者认为,尽管基层医疗人员对治疗OUD持积极态度,但更愿意治疗2型糖尿病,未来需要实施研究支持基层开具OUD药物。

要点

  • 在375名俄亥俄州基层医疗人员中,治疗2型糖尿病的意愿均值(4.4)显著高于治疗OUD(3.6)。
  • 将OUD患者转诊至专科的意愿均值(4.4)显著高于将2型糖尿病患者转诊(3.3)。
  • 患者种族(黑人 vs 白人)未导致显著的治疗决策差异。
  • 开具OUD药物的意愿为中等水平,纳曲酮均值3.7略高于丁丙诺啡3.4。
  • 最受认可的治疗是转诊至戒断为基础的住院治疗机构(均值3.9)。

适用人群与场景

  • 在俄亥俄州执业的内科医生、执业护士和医生助理,从事基层医疗或相关学科。
  • 参与者于2024年3月1日至6月6日完成评估。

研究设计与关键结果

  • 研究类型:横断面研究,采用2(主要关注点:OUD vs 2型糖尿病)×2(患者种族:黑人 vs 白人)实验设计,参与者随机分配至各条件。
  • 样本量:375名参与者提供完整数据;平均(标准差)年龄46.8(13.6)岁;女性235名(62.7%);医生(MD或DO)191名(50.9%),执业护士104名(27.7%),医生助理80名(21.3%)。
  • 主要结局:在基层治疗2型糖尿病的意愿均值(标准差)为4.4(0.1),OUD组为3.6(0.1),差异显著。
  • 转诊专科的意愿:OUD患者均值(标准差)4.4(0.1),2型糖尿病患者3.3(0.1),差异显著。
  • 患者种族未导致显著治疗差异。
  • 开具OUD药物意愿为中等:纳曲酮均值(标准差)3.7(1.2),丁丙诺啡3.4(1.3)。
  • 最受认可的治疗为转诊至戒断为基础的住院治疗机构,均值(标准差)3.9(1.2)。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管基层医疗人员对治疗OUD持积极态度,但更愿意在基层治疗2型糖尿病。
  • 作者认为,未来需要实施研究以支持基层开具OUD药物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A substantial implementation gap remains for medications for opioid use disorder (MOUDs), which prevent overdose and associated morbidities. Primary care is an important setting for expanding access opioid use disorder (OUD) treatment.

OBJECTIVE: To compare primary care professional (PCP) willingness to treat OUD vs type 2 diabetes in primary care and to assess whether patient race is associated with shaping decisions to treat either condition.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used a 2 (chief concern of OUD compared with type 2 diabetes) × 2 (Black compared with White race) experimental design. Physicians, nurse practitioners, and physician assistants practicing in primary care or a related discipline in Ohio were randomly assigned to each condition and completed assessments between March 1 and June 6, 2024.

EXPOSURE: Participants received fictitious patient profiles that were identical except that they either described the chief concern as OUD or type 2 diabetes and specified the patient's race as Black or White.

MAIN OUTCOMES AND MEASURES: Clinical and attitudinal outcomes, including willingness to treat the patient in primary care, the amount of time the participant would spend with the patient, and perceptions of the likelihood of disease stabilization, were assessed using 5-point Likert scales (1 = extremely unlikely or strongly disagree, 5 = extremely unlikely or strongly agree). For OUD only, willingness to provide MOUD treatment and harm reduction were assessed.

RESULTS: A total of 375 participants provided complete data (mean [SD] age, 46.8 [13.6] years; 235 female [62.7%]), of whom 191 (50.9%) were physicians (MD or DO), 104 (27.7%) were nurse practitioners, and 80 (21.3%) were physician assistants. Participants viewed type 2 diabetes as more complicated to treat, viewed patients with type 2 diabetes as more responsible for their diagnosis, and had more empathy toward patients with OUD. Participants were significantly more willing to treat type 2 diabetes in primary care (mean [SD], 4.4 [0.1] vs 3.6 [0.1] in the OUD condition) and more likely to refer patients with OUD to a specialist (mean [SD], 4.4 [0.1] vs 3.3 [0.1] in the type 2 diabetes condition). No significant treatment differences were found by patient race. Participants were moderately likely to prescribe an MOUD to the hypothetical patient, with slightly higher willingness to prescribe naltrexone (mean [SD], 3.7 [1.2]) than buprenorphine (mean [SD], 3.4 [1.3]). The most strongly endorsed treatment was referral to an abstinence-based residential treatment organization (mean [SD], 3.9 [1.2]).

CONCLUSIONS AND RELEVANCE: These findings suggest that PCPs have positive attitudes toward treating OUD yet more willingness to treat type 2 diabetes in primary care. Future implementation studies are needed to support MOUD prescribing in primary care.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Dhanani LY, Brook D, Hall OT, et al. Health Care Professional Willingness to Treat Opioid Use Disorder vs Type 2 Diabetes in Primary Care. JAMA Netw Open. 2025. PMID: 41026489. doi:10.1001/jamanetworkopen.2025.34680

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。